| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
153,922,000 |
| Market
Cap: |
6.15(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$37.79 - $39.95 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile IVERIC bio is biopharmaceutical company focused on the discovery and development of treatments for retinal diseases with unmet medical needs. Co.'s clinical stage product candidate, Zimura® (avacincaptad pegol), a complement C5 inhibitor. Co. is targeting the following diseases with Zimura: Geographic Atrophy, intermediate age-related macular degeneration, and autosomal recessive Stargardt disease. In addition to Zimura, Co. is developing its preclinical product candidate IC-500, a high temperature requirement A serine peptidase 1 protein inhibitor, for GA and potentially other age-related retinal diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
40,000 |
561,286 |
| Total Sell Value |
$0 |
$0 |
$1,546,400 |
$15,378,126 |
| Total People Sold |
0 |
0 |
1 |
5 |
| Total Sell Transactions |
0 |
0 |
2 |
30 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Guyer David R |
Chief Executive Officer |
• • – |
2017-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,250 |
10,997 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2017-01-03 |
4 |
S |
$4.90 |
$14,695 |
D/D |
(2,999) |
13,407 |
|
- |
|
| Wood Barbara A |
SVP, General Counsel,Secretary |
• – – |
2017-01-03 |
4 |
S |
$4.90 |
$3,308 |
D/D |
(675) |
700 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2017-01-03 |
4 |
S |
$4.90 |
$17,072 |
D/D |
(3,484) |
4,747 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2017-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,875 |
16,406 |
|
- |
|
| Wood Barbara A |
SVP, General Counsel,Secretary |
• – – |
2017-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,375 |
1,375 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2017-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,750 |
8,231 |
|
- |
|
| Bolte Axel |
Director |
– • – |
2016-12-30 |
4 |
S |
$4.83 |
$28,980 |
D/D |
(6,000) |
0 |
|
- |
|
| Wood Barbara A |
SVP,General Counsel,Secretary |
• – – |
2016-12-23 |
4 |
S |
$4.92 |
$3,670 |
D/D |
(746) |
0 |
|
- |
|
| Sblendorio Glenn |
EVP, COO & CFO, Treasurer |
• – – |
2016-12-22 |
4 |
S |
$4.85 |
$5,236 |
D/D |
(1,079) |
0 |
|
- |
|
| Novo A/s |
10% Owner |
– – • |
2016-12-15 |
4 |
S |
$4.72 |
$6,636,007 |
D/D |
(1,405,487) |
0 |
|
- |
|
| Novo A/s |
10% Owner |
– – • |
2016-12-14 |
4 |
S |
$4.97 |
$10,962,378 |
D/D |
(2,205,000) |
1,405,487 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2016-11-01 |
4 |
AS |
$34.93 |
$785,638 |
D/D |
(22,060) |
2,481 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2016-11-01 |
4 |
OE |
$10.03 |
$221,262 |
D/D |
22,060 |
24,541 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2016-10-03 |
4 |
AS |
$44.00 |
$978,899 |
D/D |
(22,060) |
2,481 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2016-10-03 |
4 |
OE |
$10.03 |
$162,586 |
D/D |
16,210 |
24,541 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2016-09-29 |
4 |
AS |
$54.13 |
$1,103,345 |
D/D |
(20,000) |
11,531 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2016-09-01 |
4 |
AS |
$52.58 |
$1,265,075 |
D/D |
(24,060) |
8,331 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2016-08-29 |
4 |
AS |
$52.80 |
$1,056,000 |
D/D |
(20,000) |
31,531 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2016-08-11 |
5 |
GD |
$0.00 |
$0 |
D/D |
90,000 |
11,531 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2016-08-10 |
5 |
GD |
$0.00 |
$0 |
D/D |
30,000 |
11,531 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2016-08-01 |
4 |
AS |
$64.39 |
$1,551,103 |
D/D |
(24,060) |
32,391 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2016-08-01 |
4 |
OE |
$10.03 |
$241,322 |
D/D |
24,060 |
56,451 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2016-07-29 |
4 |
AS |
$64.09 |
$1,284,185 |
D/D |
(20,000) |
171,531 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2016-07-01 |
4 |
AS |
$51.13 |
$1,253,934 |
D/D |
(24,060) |
32,391 |
|
- |
|
468 Records found
|
|
Page 11 of 19 |
|
|
